POSTPONED: The Challenge of the Creation of a Global Regulatory Regime for Human Germline Genome Modification: A Symposium of the International and Comparative Law Review of LMU Loyola Law School
The discovery and development of the CRISPR/Cas9 family of genome editing tools is a milestone in science and human history whose implications have not yet been fully grasped by the public and policy makers. The advent of the CRISPR era brought with it the promise of finally ridding humanity of hundreds of serious genetic diseases that condemn millions around the globe. However, when these tools are used to modify the genome of human germline cells (eggs and sperm), changes are potentially inheritable and spreadable through the population, raising numerous concerns.
This symposium aims to contribute to the ongoing conversation on the global governance of germline engineering by bringing together at Loyola Law School, Los Angeles, legal scholars, policy-makers and scientist. It will also be the occasion to launch the book Boggio A./Romano C./Almqvist J. (eds.), Human Germline Genome Modification and the Right to Science: A Comparative Study of National Laws and Policies, Cambridge University Press, 2019 (ISBN: 9781108499873).
Friday, March 13 at 10:00am to 6:30pm
919 Albany St., Los Angeles, CA 90015